Ayda Garza-montalvo, MD | |
5115 S Mccoll Rd, Edinburg, TX 78539-8278 | |
(956) 683-7900 | |
(956) 683-9910 |
Full Name | Ayda Garza-montalvo |
---|---|
Gender | Female |
Speciality | Obstetrics/gynecology |
Experience | 33 Years |
Location | 5115 S Mccoll Rd, Edinburg, Texas |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1295762268 | NPI | - | NPPES |
101344302 | Medicaid | TX |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207V00000X | Obstetrics & Gynecology | J2024 (Texas) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Doctors Hospital At Renaissance | Edinburg, TX | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Renaissance Women's Healthcare, Pa | 3476654070 | 4 |
News Archive
Officials in India say seven new cases of bird flu have been reported in the western state of Maharashtra, the site of two earlier outbreaks this year and one in neighbouring Madhya Pradesh state.
Using a series of gold nanorods, each with its own characteristic optical signature, researchers at Purdue University have developed a method for rapidly assaying the cellular composition of breast tumors.
Arena Pharmaceuticals, Inc. announced today the initiation of dosing in a Phase 1 clinical trial of APD334, a novel oral drug candidate that targets the sphingosine 1-phosphate subtype 1 (S1P1) receptor for the potential treatment of autoimmune diseases.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced that it has completed its exploratory Phase I clinical trial of RX-3117 in cancer patients.
Early symptoms of major mental illness can be subtle personality changes. Therefore, initial warning signs can often be missed, or even ignored due to conventional wisdom that suggests it's better to wait for true behavioral deterioration and prolonged patterns of abnormality before diagnosing and treating a mental illness. But experts warn that waiting until someone is so ill that the psychological sickness is unmistakable can be detrimental and can lead to long-term health concerns.
› Verified 3 days ago
Entity Name | Renaissance Women's Healthcare, Pa |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1770699639 PECOS PAC ID: 3476654070 Enrollment ID: O20070726000548 |
News Archive
Officials in India say seven new cases of bird flu have been reported in the western state of Maharashtra, the site of two earlier outbreaks this year and one in neighbouring Madhya Pradesh state.
Using a series of gold nanorods, each with its own characteristic optical signature, researchers at Purdue University have developed a method for rapidly assaying the cellular composition of breast tumors.
Arena Pharmaceuticals, Inc. announced today the initiation of dosing in a Phase 1 clinical trial of APD334, a novel oral drug candidate that targets the sphingosine 1-phosphate subtype 1 (S1P1) receptor for the potential treatment of autoimmune diseases.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced that it has completed its exploratory Phase I clinical trial of RX-3117 in cancer patients.
Early symptoms of major mental illness can be subtle personality changes. Therefore, initial warning signs can often be missed, or even ignored due to conventional wisdom that suggests it's better to wait for true behavioral deterioration and prolonged patterns of abnormality before diagnosing and treating a mental illness. But experts warn that waiting until someone is so ill that the psychological sickness is unmistakable can be detrimental and can lead to long-term health concerns.
› Verified 3 days ago
Entity Name | Renaissance Medical Foundation |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1467633867 PECOS PAC ID: 1153409867 Enrollment ID: O20080422000326 |
News Archive
Officials in India say seven new cases of bird flu have been reported in the western state of Maharashtra, the site of two earlier outbreaks this year and one in neighbouring Madhya Pradesh state.
Using a series of gold nanorods, each with its own characteristic optical signature, researchers at Purdue University have developed a method for rapidly assaying the cellular composition of breast tumors.
Arena Pharmaceuticals, Inc. announced today the initiation of dosing in a Phase 1 clinical trial of APD334, a novel oral drug candidate that targets the sphingosine 1-phosphate subtype 1 (S1P1) receptor for the potential treatment of autoimmune diseases.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced that it has completed its exploratory Phase I clinical trial of RX-3117 in cancer patients.
Early symptoms of major mental illness can be subtle personality changes. Therefore, initial warning signs can often be missed, or even ignored due to conventional wisdom that suggests it's better to wait for true behavioral deterioration and prolonged patterns of abnormality before diagnosing and treating a mental illness. But experts warn that waiting until someone is so ill that the psychological sickness is unmistakable can be detrimental and can lead to long-term health concerns.
› Verified 3 days ago
Entity Name | University Of Texas Rio Grande Valley |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1477960730 PECOS PAC ID: 3577885276 Enrollment ID: O20141209000376 |
News Archive
Officials in India say seven new cases of bird flu have been reported in the western state of Maharashtra, the site of two earlier outbreaks this year and one in neighbouring Madhya Pradesh state.
Using a series of gold nanorods, each with its own characteristic optical signature, researchers at Purdue University have developed a method for rapidly assaying the cellular composition of breast tumors.
Arena Pharmaceuticals, Inc. announced today the initiation of dosing in a Phase 1 clinical trial of APD334, a novel oral drug candidate that targets the sphingosine 1-phosphate subtype 1 (S1P1) receptor for the potential treatment of autoimmune diseases.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced that it has completed its exploratory Phase I clinical trial of RX-3117 in cancer patients.
Early symptoms of major mental illness can be subtle personality changes. Therefore, initial warning signs can often be missed, or even ignored due to conventional wisdom that suggests it's better to wait for true behavioral deterioration and prolonged patterns of abnormality before diagnosing and treating a mental illness. But experts warn that waiting until someone is so ill that the psychological sickness is unmistakable can be detrimental and can lead to long-term health concerns.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Ayda Garza-montalvo, MD 5115 S Mccoll Rd, Edinburg, TX 78539-8278 Ph: (956) 683-7900 | Ayda Garza-montalvo, MD 5115 S Mccoll Rd, Edinburg, TX 78539-8278 Ph: (956) 683-7900 |
News Archive
Officials in India say seven new cases of bird flu have been reported in the western state of Maharashtra, the site of two earlier outbreaks this year and one in neighbouring Madhya Pradesh state.
Using a series of gold nanorods, each with its own characteristic optical signature, researchers at Purdue University have developed a method for rapidly assaying the cellular composition of breast tumors.
Arena Pharmaceuticals, Inc. announced today the initiation of dosing in a Phase 1 clinical trial of APD334, a novel oral drug candidate that targets the sphingosine 1-phosphate subtype 1 (S1P1) receptor for the potential treatment of autoimmune diseases.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced that it has completed its exploratory Phase I clinical trial of RX-3117 in cancer patients.
Early symptoms of major mental illness can be subtle personality changes. Therefore, initial warning signs can often be missed, or even ignored due to conventional wisdom that suggests it's better to wait for true behavioral deterioration and prolonged patterns of abnormality before diagnosing and treating a mental illness. But experts warn that waiting until someone is so ill that the psychological sickness is unmistakable can be detrimental and can lead to long-term health concerns.
› Verified 3 days ago
Jennifer Leigh Griesel, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2821 Michael Angelo, Ste 400, Edinburg, TX 78539 Phone: 956-362-3594 | |
Luis A. Ramirez, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2821 Michael Angelo Ste 100, Edinburg, TX 78539 Phone: 956-683-6073 Fax: 956-686-7507 | |
Selina E Tristan, APRN,FNP-C Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 611 Bishop St, Edinburg, TX 78539 Phone: 956-792-1636 | |
Cherie J Johnson, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 2821 Michaelangelo Dr, Ste 401, Edinburg, TX 78539 Phone: 956-362-2470 Fax: 956-362-2487 | |
Dr. Kristy Morales, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 4302 S Sugar Rd Ste 206, Edinburg, TX 78539 Phone: 956-682-6146 Fax: 956-631-0441 | |
Mr. Padraic Chisholm, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 910 S Closner Blvd, Edinburg, TX 78539 Phone: 956-380-3441 | |
Dr. Saul Daniel Rivas, MSPH, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2821 Michaelangelo Dr, Edinburg, TX 78539 Phone: 956-362-3553 Fax: 956-362-3529 |